• Home
  • Search Results

Search Results

Young Adult (18-34)
2364 studies match your search
Open

Basal-like PDAC treated with Gemcitabine, Erlotinib and nab-paclitaxel (PANGEA).

Are you a patient with advanced basal-like pancreatic adenocarcinoma? If so this could the a Trial for you to as this is a Phase I/II trial is to evaluate the safety, efficacy and tolerability of low-dose EGFR inhibitors in combination with bi-weekly gemcitabine/nab-paclitaxel (GnP) in subjects with basal tumors

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pancreatic)
Open

Suicidality in Adolescents Following Psychiatric Hospitalization

Is your child being hospitalized at UNC Youth Behavioral Health for suicidal thoughts or behaviors? If so, you may be eligible to participate in a research study to identify the risk factors associated with recurrence of suicidal thoughts after psychiatric hospitalization. Both you and your child must participate to be eligible for the research study. Compensation provided.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Mental and Emotional Health
  • Parents of Children
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial), Ovarian)
Not currently enrolling

Alcohol Behavior Study

In this study, we want to see how people's bodies react to alcohol in the lab and outside of it. We want to examine responses to alcohol and drinking behavior in people who drink alcohol regularly.

Age & Gender
  • 21 years ~ 44 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • UNC or UNC Health employees
  • and 3 more
Not currently enrolling

Birth Experience and Stress Study

In this study, we want to see how giving birth affects stress chemicals in the body. We will focus on a stress hormone called cortisol and check its levels in people who gave birth, from 3 to 12 months after giving birth.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Women's Health
Visit Location
100% Remote (online, phone, text)
Open

Discrimination and Pregnancy Study

Are you 14 to 20 weeks pregnant with one baby? If so, you may be able to take part in a study on how stress and discrimination during pregnancy affect your health. We want to prevent high blood pressure and give better care to pregnant women.

Age & Gender
  • 18 years ~ 45 years
  • Female
Study Interest
  • Blood Pressure
  • Minority Health
  • Women's Health
  • and 2 more
Open

Venetoclax, MLN9708 and Dexamethasone for Relapsed or Refractory Light Chain Amyloidosis

Have you been diagnosed with relapsed or refractory light chain amyloidosis? If so, you may be able to take part in a research study looking at the safety and tolerability of giving Venetoclax, MLN9708 (ixazomib citrate) and Dexamethasone to patients with relapsed or refractory light chain amyloidosis.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Other Cancers)
Open

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission

Have you been diagnosed with aggressive B-cell lymphomas and received CAR-T treatment? If so, you may be able to take part in a research study. This study is looking at the efficacy of giving an investigational drug called Epcoritamab in comparison with no treatment. The participants should have received CAR-T treatment but did not have complete remission.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Glands and Hormones
Not currently enrolling

Fertility Expectations, Experience, and Life Intentions (FEEL) Study

This study seeks to understand how different things about your life, like your upbringing, might affect how you feel about having kids in the future. By looking at how your background and experiences shape your thoughts on having children, we hope to learn more about what factors influence people's decisions about starting a family.

Age & Gender
  • 25 years ~ 35 years
  • Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Mental and Emotional Health
  • Women's Health
  • and 4 more
Visit Location
100% Remote (online, phone, text)
Open

A PHASE 1/2A, OPEN-LABEL, DOSE-ESCALATION AND DOSE-EXPANSION FIRST-IN-HUMAN STUDY OF THE SAFETY, TOLERABILITY, ACTIVITY, AND PHARMACOKINETICS OF REGN10597 (ANTI PD-1-IL2RA-IL2 FUSION PROTEIN) IN PATIENTS WITH ADVANCED SOLID ORGAN MALIGNANCIES

Do you have kidney or bladder cancer. You may be able to participate in a research study to find out if the investigational drug REGN10597 is safe, tolerable, and effective in treating kidney and bladder cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Kidney)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research